Laurie Gaspar, MD
Professor Emerita, Radiation Oncology

Photo
Medical School:
  • MD, The University of Western Ontario - Schulich School of Medicine & Dentistry (1982)
Graduate School :
  • MBA, University of Michigan (2004)
Internship:
  • The University of Western Ontario (1983)
Residency:
  • The University of Western Ontario, Radiation Oncology (1982)
Languages: English
Department: Radiation Oncology

Professional Titles

  • Professor Emerita, Radiation Oncology
  • Former Chair
  • Professor

Recognition & Awards

  • America's Best Physicians, America's Best Physicians (2016)
  • Best Doctors in America, Best Doctors (2015)
  • Best Doctors in America, Best Doctors (2012)
  • Best Doctors in America, Best Doctors (2010)
  • Best Doctors in America, Best Doctors (2008)
  • Best Doctors in America, Best Doctors (2006)
  • Top Doctors Denver, 5280 (2006)

Publications

  • Rusthoven CG, Yeh N, Gaspar LE. Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice. Cancer J. 2015 Sep-Oct;21(5):404-12. PubMed PMID: 26389766
  • Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol. 2015 Jun;16(6):e270-8. PubMed PMID: 26065612
  • Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun;123(2):251-7. PubMed PMID: 25920710
  • Brennan D, Schubert L, Diot Q, Castillo R, Castillo E, Guerrero T, Martel MK, Linderman D, Gaspar LE, Miften M, Kavanagh BD, Vinogradskiy Y. Clinical validation of 4-dimensional computed tomography ventilation with pulmonary function test data. Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):423-9. PubMed PMID: 25817531
  • Wozniak AJ, Moon J, Thomas CR Jr, Kelly K, Mack PC, Gaspar LE, Raben D, Fitzgerald TJ, Pandya KJ, Gandara DR. A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer. 2015 Sep;16(5):340-7. PubMed PMID: 25703100
  • Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar;122(1):135-43. PubMed PMID: 25524817
  • Gan GN, Weickhardt AJ, Scheier B, Doebele RC, Gaspar LE, Kavanagh BD, Camidge DR. Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib. Int J Radiat Oncol Biol Phys. 2014 Jan 22. [Epub ahead of print] PubMed PMID: 24462383
  • Chen Y, Moon J, Pandya KJ, Lau DH, Kelly K, Hirsch FR, Gaspar LE, Redman M, Gandara DR. A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer. Front Oncol. 2013;3:219. PubMed PMID: 24010120
  • Lin NU, Wefel JS, Lee EQ, Schiff D, van den Bent MJ, Soffietti R, Suh JH, Vogelbaum MA, Mehta MP, Dancey J, Linskey ME, Camidge DR, Aoyama H, Brown PD, Chang SM, Kalkanis SN, Barani IJ, Baumert BG, Gaspar LE, Hodi FS, Macdonald DR, Wen PY, Response Assessment in Neuro-Oncology (RANO) group. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol. 2013 Sep;14(10):e407-16. PubMed PMID: 23993385
  • Lin NU, Lee EQ, Aoyama H, Barani IJ, Baumert BG, Brown PD, Camidge DR, Chang SM, Dancey J, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Lamborn KR, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wefel JS, Wen PY, Response Assessment in Neuro-Oncology (RANO) group. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol. 2013 Sep;14(10):e396-406. PubMed PMID: 23993384
  • Compton JJ, Gaspar LE, Shrieve DC, Wilson LD, Griem KL, Amdur RJ, Lee WR. Resident-reported brachytherapy experience in ACGME-accredited radiation oncology training programs. Brachytherapy. 2013 Nov-Dec;12(6):622-7. PubMed PMID: 23973187
  • Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug;114(1):111-6. PubMed PMID: 23729276
  • Amin NP, Miften M, Thornton D, Ryan N, Kavanagh B, Gaspar LE. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer. Med Dosim. 2013 Autumn;38(3):320-6. PubMed PMID: 23611631
  • Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol. 2013 May;112(3):467-72. PubMed PMID: 23462853
View All (14 Total) View Less

Professional Memberships

  • American Society of Clinical Oncology (ASCO), Member
  • Society for Neuro-Oncology, Member
  • American Society for Radiation Oncology (ASTRO), Member, Prior Secretary/Treasurer
  • International Society for the Study of Lung Cancer (IASLC), Board Member
  • National Cancer Institute (NCI) Thoracic Malignancy Steering Committee, Co-Chair

Practice Locations

University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Hospital Affiliation
  • University of Colorado Hospital
  • Denver Health Medical Center
  • Veterans Affairs Medical Center
Center Affiliations

Specialty Information

Specialties
  • Radiation Oncology, Board Certification
Conditions & Treatments
  • Brain and Nervous System
  • Brain and Nervous System - Brain Tumors
  • Cancers - Lung Cancer
  • Cancers - Radiation Therapy
  • Cancers - Brain Cancer
  • Cancers - Thoracic (Tracheal, Esophageal)
  • Cancers
Clinical Interests
My many clinical interests include radiation treatment for lung cancers and brain tumors. I am experienced in the use of stereotactic radiosurgery and fractionated stereotactic radiation and intensity modulated radiation therapy.

Care Philosophy
I strive to provide patients with all the information they need to make an informed decision about their treatment.

Personal Interests
In my spare time, I enjoy bridge and reading and walking my dogs.

Volunteer Activities
I am currently involved in patient advocacy committees in the International Association for the Study of Lung Cancer (IASLC).

General Information

Medical Schools:
  • MD, The University of Western Ontario - Schulich School of Medicine & Dentistry (1982)
Graduate Schools:
  • MBA, University of Michigan (2004)
Internships:
  • The University of Western Ontario (1983)
Residency Programs:
  • The University of Western Ontario, Radiation Oncology (1982)
Languages: English
Department: Radiation Oncology
;